Biotech & Pharma Compliance, From GxP to Part 11-Ready
Fintra maps FDA 21 CFR Part 11 and GxP requirements onto a seeded security baseline, adds HIPAA for clinical data, and governs the AI agents that touch trial and patient records - with evidence at every step.
The compliance landscape for biotech and pharma
Life-sciences compliance splits into the regulated-process world and the security world. FDA 21 CFR Part 11 governs electronic records and signatures in regulated systems; GxP (GLP, GCP, GMP) governs how you conduct labs, trials, and manufacturing; and clinical data that is also protected health information brings HIPAA. Buyers and partners layer SOC 2 and ISO 27001 on top. Fintra seeds the security frameworks and maps the FDA/GxP world onto the same controls.
| Framework | What it covers | Fintra role |
|---|---|---|
| FDA 21 CFR Part 11 | Electronic records & signatures | Prepare-for - maps controls & evidence |
| GxP (GLP/GCP/GMP) | Good practice for labs, trials, manufacturing | Prepare-for - evidence organization |
| HIPAA (if clinical) | Protected health information safeguards | SEEDS - Security Rule control library |
| SOC 2 | Security assurance for platforms | SEEDS - Trust Services Criteria |
| ISO 27001 | Information security management system | SEEDS - Annex A control library |
Who this is for and when it bites
- Biotechs standing up validated systems that must meet Part 11 electronic-record and e-signature rules
- CROs and clinical platforms handling patient data that is also ePHI under HIPAA
- Sponsors and labs whose GxP audit readiness lives in binders and disconnected validation docs
- Software vendors to pharma asked for SOC 2 and ISO 27001 before integration
- Teams applying AI to trial data, pharmacovigilance, or lab records
How Fintra and SentriAI help
Bridge the security and regulated-process worlds
- 1
Seed HIPAA & security
HIPAA, SOC 2, and ISO 27001 ship as a mapped control library, so the security backbone is evidenced once.
- 2
Map Part 11
Align electronic-record, audit-trail, and e-signature requirements onto controls and organize the validation evidence.
- 3
Organize GxP
Keep GxP procedures, training, and validation records as evidence-backed controls, ready for an inspection.
- 4
Govern clinical AI
Record a policy verdict on every AI-agent action over trial and patient data, so automated decisions are provable.
Governing AI agents that touch clinical trial and patient data
The new risk in biotech and pharma is not just your cloud config - it is the AI agents and automations now reading and acting on clinical trial and patient data. Config scanners like Vanta or Drata do not see that layer. Fintra does: for every action, the Policy Decision Point returns a verdict - allow, allow-with-logging, step-up, human-review, or recommend-block - with an Action Trust Score and a reason, and writes it to a tamper-evident, hash-chained evidence ledger. Those recorded decisions are the operating evidence behind your FDA 21 CFR Part 11 and HIPAA obligations, extended to your automation layer.
- Every agent access to clinical trial and patient data produces a policy verdict recorded as evidence, not just a log line
- An Action Trust Score per agent, so one that drifts loses standing before it causes a finding
- Decision Intelligence: an auditor-grade explanation of why any single action got the verdict it did
- A hash-chained ledger you can verify, so the evidence can be shown to be untampered
Frequently asked questions
Can Fintra validate our systems for FDA 21 CFR Part 11?
No - Part 11 compliance and computer-system validation are assessed by the FDA and your quality/validation function. Fintra is prepare-for: it maps Part 11’s electronic-record and e-signature requirements onto controls and organizes the validation evidence so an inspection is defensible.
What is seeded for life-sciences companies?
HIPAA (for clinical data that is ePHI), SOC 2, and ISO 27001 are seeded - a mapped control library with evidence requirements. FDA Part 11 and GxP are prepare-for, mapped onto the same controls but not certified by Fintra.
How does AI governance apply to clinical data?
As AI agents analyze trial data, pharmacovigilance signals, or patient records, Fintra records a policy verdict on each action to a tamper-evident, hash-chained ledger - an audit trail for how automated decisions over regulated clinical data were bounded and made.
Does the tamper-evident ledger help with Part 11 audit trails?
It complements them. Part 11 requires secure, computer-generated audit trails in your regulated systems; Fintra’s hash-chained decision ledger provides the same tamper-evidence for the AI-governance decisions layered on top, and organizes the surrounding evidence for review.
Does Fintra replace our auditor, assessor, or authorizing body?
No. Fintra is the control, policy, and evidence layer - it makes your program continuously audit-ready and cuts preparation from weeks to days. The audit, certification, attestation, or authorization itself is always performed by an independent, qualified party.
Stay in the loop
One practical finance briefing a week - new guides, checklists, and benchmarks.
Bridge GxP and security in one program
Seed HIPAA and security, map Part 11 and GxP, and govern AI on clinical data.
Talk to us